Site icon pharmaceutical daily

Worldwide Single-use Bioreactors Industry to 2030 – Market Trends and Global Forecasts – ResearchAndMarkets.com

DUBLIN–(BUSINESS WIRE)–The “Single-Use Bioreactors Market by Type of Reactor, Cell Culture System, End-User, and Geography: Industry Trends and Global Forecasts, 2020-2030” report has been added to ResearchAndMarkets.com’s offering.

The report features an extensive study of the current landscape and the likely future potential of single-use bioreactors, over the next decade. The study also features an in-depth analysis, highlighting the capabilities of various industry stakeholders engaged in this field.

The modern biopharmaceutical industry, which is poised for significant growth over the coming years, is characterized by several blockbuster therapies and a robust pipeline of product/therapy candidates. Traditionally, stainless steel bioreactors were the preferred choice for production of biologics; however, over the past couple of decades, biopharmaceutical manufacturing has gradually witnessed a shift towards the use of single-use technologies. Apart from low contamination risk and better product yield, single-use bioreactors are easy-to-install and have a much smaller footprint, compared to the traditional stainless steel systems. In addition to enabling substantial cost savings (by eliminating the need for additional steps, such as sterilization, cleaning, and maintenance), single-use bioreactors are also less demanding of energy and are known to help conserve resources, such as water and CO2. Moreover, the upfront cost of such bioprocessing solutions is also not very high.

To date, many biopharmaceutical companies and contract service providers have upgraded their manufacturing infrastructure and facilities to include more of single-use systems. In addition, there are a number of companies that are now involved in the development and production of single-use bioreactors. Several of these players are now focusing on incorporating a variety of additional features, including provisions for alerts/alarms, built-in system process control sensors, electronic process logs, remote monitoring features, touch screens, and advanced safety provisions, in their proprietary offerings. We are also led to believe that the COVID-19 pandemic is likely to result in an increased demand for advanced biomanufacturing solutions.

In fact, single-use bioreactors are extensively being used for the production of various COVID-19 vaccines. This presents lucrative opportunities for companies engaged in single-use bioreactors domain. The overall single-use bioreactors market is anticipated to witness substantial growth, primarily driven by the increasing adoption of such manufacturing solutions among small companies and startups in the coming years.

Companies Mentioned

Key Questions Answered

Key Topics Covered:

1. PREFACE

2. EXECUTIVE SUMMARY

3. INTRODUCTION

4. MARKET LANDSCAPE

5. KEY INSIGHTS

6. COMPANY PROFILES

7. PARTNERSHIPS AND COLLABORATIONS

8. PRODUCT COMPETITIVENESS ANALYSIS

9. COMPANY COMPETITIVENESS ANALYSIS

10. BRAND POSITIONING ANALYSIS

11. PATENT ANALYSIS

12. MARKET FORECAST

13. CASE STUDY: KEY TECHNOLOGICAL INNOVATIONS IN THE SINGLE-USE BIOREACTORS INDUSTRY

14. SWOT ANALYSIS

15. CONCLUSION

16. EXECUTIVE INSIGHTS

17. APPENDIX I: TABULATED DATA

18. APPENDIX II: LIST OF COMPANIES AND ORGANIZATIONS

19. APPENDIX III: LIST OF BUSINESSES OFFERING ACCESSORIES, EQUIPMENT, AND AUTOMATION SOLUTIONS

For more information about this report visit https://www.researchandmarkets.com/r/d1b1h2

Contacts

ResearchAndMarkets.com

Laura Wood, Senior Press Manager

press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470

For U.S./CAN Toll Free Call 1-800-526-8630

For GMT Office Hours Call +353-1-416-8900

Exit mobile version